Top Cosmetics companies in Germany by Price to Book Ratio (P/B)
Germany
# |
Name |
Price to Book Ratio (P/B) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
7.27 |
Jan. 14, 2025 | USD 26.38 | -0.18% |
|
Germany |
|
| 2 |
3.73 |
Jan. 14, 2025 | USD 41.22 | 0.60% |
|
Germany |
|
| 3 |
3.56 |
Jan. 14, 2025 | USD 40.61 | -1.64% |
|
Germany |
|
| 4 |
3.46 |
Jan. 14, 2025 | USD 99.35 | -2.63% |
|
Germany |
|
| 5 |
2.65 |
Jan. 14, 2025 | USD 15.97 | 3.61% |
|
Germany |
|
| 6 |
2.54 |
Jan. 14, 2025 | USD 20.07 | -0.42% |
|
Germany |
|
| 7 |
1.59 |
Jan. 14, 2025 | USD 4.96 | -2.24% |
|
Germany |
|
| 8 |
1.51 |
Jan. 14, 2025 | USD 75.23 | 0.40% |
|
Germany |
|
| 9 |
1.06 |
Jan. 14, 2025 | USD 36.59 | -0.52% |
|
Germany |
|
| 10 |
1.01 |
Jan. 14, 2025 | USD 0.46 | 0.83% |
|
Germany |
|
| 11 |
0.33 |
Jan. 14, 2025 | USD 1.66 | -6.08% |
|
Germany |
Frequently Asked Questions
-
Which Cosmetics company in Germany has the highest Price to Book Ratio (P/B) ?
The Cosmetics company in Germany with the highest Price to Book Ratio (P/B) is PharmaSGP Holding SE (XETRA: PSG.DE) at 7.27.
-
Which Cosmetics company in Germany has the lowest Price to Book Ratio (P/B) ?
The Cosmetics company in Germany with the lowest Price to Book Ratio (P/B) is Mister Spex SE (Frankfurt Stock Exchange: MRX.F) at 0.33.
-
What are the top 10 Cosmetics companies in Germany by Price to Book Ratio (P/B) ?
The top 10 Cosmetics companies in Germany by Price to Book Ratio (P/B) are PharmaSGP Holding SE, Dermapharm Holding SE, Fielmann Aktiengesellschaft, Symrise AG, M1 Kliniken AG, Douglas AG, SynBiotic SE, Henkel AG & Co. KGaA, Bijou Brigitte modische Accessoires Aktiengesellschaft and EuroEyes International Eye Clinic Limited.
-
What are the bottom 10 Cosmetics companies in Germany by Price to Book Ratio (P/B) ?
The bottom 10 Cosmetics companies in Germany by Price to Book Ratio (P/B) are Mister Spex SE, EuroEyes International Eye Clinic Limited, Bijou Brigitte modische Accessoires Aktiengesellschaft, Henkel AG & Co. KGaA, SynBiotic SE, Douglas AG, M1 Kliniken AG, Symrise AG, Fielmann Aktiengesellschaft and Dermapharm Holding SE.